Dermapharm Holding SE Logo

Dermapharm Holding SE (DMP)

FSX

Currency in EUR
37.30
-0.40 (-1.06%)

Closed

Oct 5, 2026

Day's Range

37.30
37.30

52 wk Range

32.30
50.70

Overview - DMP - Dermapharm Holding SE

Key Statistics

Valuation

Enterprise Value

2.87B

P/E (Trailing)

‪13.86‬

P/E (Forward)

‪12.94‬

PEG Ratio

‪0.67‬

Price / Sales (TTM)

‪1.60‬

Price / Book

‪3.53‬

EV / EBITDA

‪9.27‬

Profitability

Gross Margin

‪69.30%‬

Profit Margin

‪12.39%‬

Operating Margin

‪15.86%‬

Return on Assets

‪7.11%‬

Return on Equity

‪25.56%‬

Ownership

Shares Outstanding

49.54M

Float

6.46M

Held by Insiders

‪89.29%‬

Held by Institutions

‪7.97%‬

Price stats

Beta

‪0.84‬

50-Day Avg

‪41.59‬

200-Day Avg

‪41.80‬

Dividends

Payout Ratio

‪31.77%‬

Frequency

Annual

Analyst Consensus

Buy

6 analysts

News Teaser - DMP - Dermapharm Holding SE

News & Analysis

View all news

Market Cap - DMP - Dermapharm Holding SE

Peers - DMP - Dermapharm Holding SE

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.

Profile Summary - DMP - Dermapharm Holding SE

About

Dermapharm Holding SE is a leading manufacturer of branded pharmaceuticals and other healthcare products, founded in 1991 by Wilhelm Beier and headquartered in Grünwald near Munich, Germany. The company operates an integrated business model encompassing in-house product development, production, quality management, and…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees3.61K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.